breast cancer; malignant breast neoplasm; breast carcinoma

FDA Approves Sacituzumab Govitecan for First-Line Metastatic Triple-Negative Breast Cancer The U.S. Food and Drug Administration (FDA) has granted approval for sacituzumab govitecan (Trodelvy) as a first-line treatment for patients …

Addressing the Systemic Gender Gap in Healthcare Diagnostics and Investment The healthcare industry is shifting toward a life-course approach to women’s health, moving beyond reproductive care to address systemic diagnostic …

Circulating tumor DNA (ctDNA) testing is a rapidly evolving tool in oncology, used to detect molecular residual disease after cancer treatment. While these liquid biopsies can identify cancer markers before …